About TransOral Robotic Surgery (TORS) скачать в хорошем качестве

About TransOral Robotic Surgery (TORS)

Led by Ear, Nose and Throat/Head and Neck Surgery Chairman Eric M. Genden, MD, Mount Sinai's TransOral Robotic Surgery (TORS) Program was established as one of the first of its kind worldwide, and it remains one of only a handful today. An early adopter of the DaVinci Surgical System, the Department of Ear, Nose and Throat/Head and Neck Surgery embraced this state-of-the-art technology for treating tumors in the back of the throat, tonsils or base of the tongue to ultimately improve patients’ recovery, cosmetic appearance, and ability to speak and swallow. In the past, these tumors presented a significant challenge to reach, and traditionally were removed by surgeons through a large incision stemming from the lip to the throat. However, the advent of the robotic technology approach, which was approved by the FDA in 2009, brought about a momentous paradigm shift in the removal of these benign and malignant tumors and the benefits it delivers to patients. Now with TORS, the length of the procedure to remove these tumors is reduced to 1 1/2 hours from 10-12 hours and patients experience the benefits of less post-operative discomfort, shorter hospital stays, no visible scarring, and a speedier recovery. The TORS team at Mount Sinai is comprised of fellowship trained head and neck oncology experts with years of experience employing robotic surgery to early stage through advanced cases. For more information, visit www.mountsinai.org/ent or call 212-241-9410.